Abstract Staphylococcal enterotoxin B (SEB) and toxic shock syndrome toxin-1 are the super antigens responsible for diseases such as staphylococcal food poisoning and toxic shock syndrome. At low serum concentrations, SEB can trigger toxic shock, profound hypotension and multi organ failure and hence is recognized as biowarfare molecule. In this study, a multidomain fusion protein (r-TE) was generated with specificity for SEB and toxic shock syndrome toxin (Tsst-1). The fusion gene comprising the conserved regions of seb and the tsst genes was codonoptimized for expression in Escherichia coli and encoded a 26 kDa recombinant multidomain chimeric protein (r-TE). Hyperimmune antiserum raised against r-TE specifically reacted with SEB (*28 kDa) and Tsst-1 (*22 kDa) components during Western blot analysis and by plate ELISA in confirmed toxin producing strains of S. aureus. The antigenicity of the SEB component of the r-TE protein was also confirmed using TECRA kit. The described procedure of creating a single protein molecule carrying components of two different toxins whilst still retaining the original antigenic determinants of individual toxins proved highly advantageous in the development of rapid, reliable and cost effective immunoassays and may also have the potential to serve as candidate molecule for vaccine studies.
Introduction
Staphylococcus aureus, a Gram-positive cocci, with potential to cause clinical and food-borne infections by secreting a variety of extra cellular toxins is responsible for many nosocomial infections, besides being the main causative agent of food intoxication [1, 2] . Among the array of toxin components being possessed by this pathogen, enterotoxin B (SEB) and toxic shock syndrome toxin (Tsst-1) of S. aureus are the important virulence factors that play vital role in the pathogenicity. SEB is the primary cause of staphylococcal food poisoning and a potent mitogen, whereas Tsst may lead to toxic shock syndrome which is potentially fatal. Both Tsst-1, and SEB belong to a family of superantigens, at very low concentrations, these super antigens induces polyclonal immune response by direct binding to class II major histocompatibility complex proteins and T-cell receptors on the surfaces of B and T cells without being internalized and processed like a normal antigen [3] [4] [5] . At low serum concentrations, SEB can also trigger a toxic shock and profound hypotension resulting in multi organ failure [6, 7] .
Both SEB and Tsst owing to their virulence potential, qualify as biowarfare molecules [8] [9] [10] . In the event of biological emergency, the disease is likely to be confused with naturally occurring epidemic, further confounded by difficulties for the timely diagnosis which could lead to delay in the initiation of treatment or control procedures. An early diagnosis of the disease will enable medical/rapid response teams to implement appropriate defensive measures for an effective action. Though the detection systems based on the PCR are specific and accurate, the main disadvantage happens to be their inability to correlate to the expression of toxin components by the organism. Certain immunoassays have been reported for the detection of these toxins individually, but so far there is no single system available to detect both of these toxin molecules simultaneously. Moreover, the commercially available immunoassays for the detection of individual toxin are costly. Simultaneous detection of both of these toxins in one assay can also make the product economical.
In the present study, we followed a strategy of combining together the conserved domains of tsst-1 and seb to form a single fusion gene and to express the multidomain recombinant chimeric protein in Escherichia coli without exhibiting toxicity to the host cells. The polyclonal antibodies thus generated were successfully evaluated for the detection of Tsst-1 or SEB containing S. aureus from different sources by ELISA as well as by Western blot analysis. Detection of these two toxins simultaneously by a single immunoassay would have advantages in terms of rapidity, convenience and cost saving during biological emergencies.
Materials and Methods

Bacterial Strains and Materials
The bacterial strains used in this study were obtained from ATCC and National Collection of Industrial Microorganisms (NCIM), clinical isolates from SDM Medical college, Dharwad and twelve S. aureus strains isolated from food samples collected from different sources of Mysore. Characterization of this important foodborne micro-organism was carried out by standard conventional biochemical identification procedures. All of the standard strains and isolates were checked for the presence of the genes under study (seb and tsst) using PCR primers developed in house (Table 1 ). All these standard strains and isolates were used for evaluation of immunogenicity of r-chimeric protein. The enzymes and chemicals used for DNA manipulation were purchased from Fermentas (India). The oligonucleotides were obtained from MWG Biotech Pvt Ltd. (Bangalore). The plasmid pRSET A and E. coli host BL21 (DE3) pLysS were purchased from Invitrogen (India).
PCR Amplification of tsst and seb Genes and Plasmid Construction Construction of fusion gene and plasmid were carried out as per the procedure described by [11] , the conserved portions of tsst-1 and seb were amplified by PCR, using S. aureus TSST-Japan and ATCC 51740 whole genomic DNA respectively as template. Primers of tsst-1 gene fragment (323 bps) were designed to insert BamH I and Sac I sites to the 5 0 and 3 0 ends, similarly, primers of seb gene fragment (332 bps) were designed to insert SacI and HindIII sites to the 5 0 and 3 0 ends via PCR ( Table 2) . PCR was performed in 25 ll reaction volume containing 400 nM of each primer, 200 lM of each dNTP, 1.0 U Pfu polymerase (MBI Fermentas), 1.5 mM of MgSO 4 in 19 PCR buffer (MBI Fermentas) with 50 ng of template DNA. PCR was carried out through 30 cycles in Eppendorf master cycler gradient (Hamberg, Germany) thermal cycler at 94°C for 1 min denaturation, 54°C for 1 min annealing and 72°C for 2 min extension. The DNA was denatured for 5 min in the beginning and finally extended for 15 min at 72°C. The amplified PCR products were restricted with appropriate enzymes, separated on 1 % agarose gel and purified by Genelute gel extraction kit (Sigma).
Fusion gene, codon-optimized for E. coli expression, was first generated by ligation of PCR amplified products encoding conserved domains of tsst-1 and seb using T4 DNA ligase and subsequent PCR amplification with Rev-TAGAAGCTTGTTTGTCAGTTTGATGCG forward primer of tsst-1 and reverse primer of seb to get fusion gene (655 bp). The resultant 655 bp gene (r-TE) was ligated in frame into the BamHI and HindIII sites of pRSET A to generate the plasmid pR-r-TE, which expresses a chimeric protein of 26 kDa. The ligated product was transformed into chemically competent E. coli BL21 (DE3) pLysS cells and selected on ampicillin plates [12] . Transformants were subjected to direct colony PCR screening, using tsst-1 forward primer and seb reverse primer to identify recombinants harboring the synthetic r-TE gene.
Expression and Purification of r-Chimeric Protein
The E. coli cells carrying the recombinant plasmid were grown at 37°C in Luria-Bertani broth with 50 lg/ml of ampicillin at 200 rpm. When A 600 reached 0.6, IPTG was added to a final concentration of 1 mM. After 5 h of induction, cells were harvested by centrifugation at 4,0009g for 20 min. The recombinant protein with amino terminal hexa histidine residues was subjected to purification by IMAC method using Ni-NTA (Qiagen) as a chelating resin under denaturing conditions using guanidine hydrochloride as denaturing agent. All the samples were examined on 12 % sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein content was estimated by the method of Lowry et al. [13] . For immunization purpose, the six-histidine tag was removed from 200 lg of purified chimeric protein by cleavage with 0.1 U of biotinylated thrombin (Novagen, India) at 16°C for 16 h. The cleaved recombinant protein was then purified by passage through streptavidin-agarose (Novagen) to remove the biotinylated thrombin and then a nickel charged Hi-Trap column to remove cleaved six-histidine tags and any remaining uncleaved His-tagged chimeric protein moieties.
Preparation of Hyperimmune Polyclonal Antiserum
Hyperimmune anti-r-chimeric protein polyclonal antiserum was generated by subdermal immunization of male BALB/ c mice (6 weeks old) with affinity-purified r-chimeric protein. Primary immunization of each animal was done with 50 lg of purified r-chimeric protein in Freund's complete adjuvant. Two boosts of 10 lg each of r-chimeric protein in Freund's incomplete adjuvant followed on days 14 and 28.
Antibody Titer by Indirect Plate ELISA
The antibody titer of immunized mice sera was measured by indirect plate-ELISA using r-TE protein as antigen [14] . 50 ll of 10 lg/ml r-TE protein in 50 mM carbonate buffer (pH 9.6) was coated on to microtiter plates, incubated at 4°C overnight, followed by blocking with 5 % non fat milk 
SEB Analysis
The r-TE protein was evaluated for the presence of native antigenic determinants of SEB using a TECRA VIA Staphylococcus enterotoxin kit (TECRA International).
ELISA
To determine whether the anti-r-TE antibody also bound native toxins, an antibody ELISA was performed according to the method of Harlow and Lane [15] using plastic 96-well microtiter plates (PolySorb; Nunc) as the solid phase. The plates were coated with 100 ll diluted antigen and incubated at room temperature for 1 h. Each well was washed twice in PBS, and the remaining wall area was blocked with 3 % BSA in PBS for 2 h at room temperature.
A dilution of the anti-r-TE antibody in 1 % BSA in PBS/ 0.05 % Tween was added and incubated for 2 h. Each well was washed three times with PBS/0.05 % Tween. Antimice IgG conjugated to horseradish peroxidase was added and incubated for 1 h, washed three times and developed using O-phenylenediamine dihydrochloride (Sigma) and H 2 O 2 in 0.15 M phosphate citrate buffer (pH 5.0), and the A 450 was measured. Initial assays were performed to determine the antigen concentration that best discriminated between ELISA reactions of culture supernatant from confirmed toxin-producing organisms and non-toxin producing organisms. Chequer-board titrations were performed with 50-, 100-and 200-fold serum dilutions and antigen concentrations per well of 5, 25, 50 and 100 ng. In subsequent assays to determine sensitivity and specificity, plates were coated with the predetermined antigen concentrations (5, 25, 50 and 100 ng). Incubations were performed with 50-and 20,000-fold dilutions of primary sera and secondary antibody conjugate, respectively. Individual culture supernatant samples were tested in duplicate and the means of the two measurements were calculated for analysis. Paired measurements that differed by greater than 10 % were retested. One negative control serum sample from unimmunized mice was included, in duplicate, on each plate as a quality control measure.
Evaluation of the Detection Systems
Evaluation of the hyper immune sera based Western blot detection system was carried out using 216 food, clinical and environmental samples. Simultaneously the samples were tested for the presence of seb and tsst genes by PCR and expression of SEB toxin using commercially available TECRA kit.
Results
Design of a Novel Tsst-SEB Toxin Chimeric Protein
In order to create a recombinant chimeric protein that could be useful in simultaneous detection of Tsst and SEB toxins, we focused on antigenic domains of the Tsst and SEB toxin by selecting truncated portions. Care has been taken during designing of primers for amplification of tsst-seb, genes to accommodate open reading frame of one gene in view of open reading frame of preceding gene. The fusion gene designated r-TE contains conserved domains of tsst and seb was designed to be in frame with the initiator codon and N terminal six histidine tag encoding sequence provided by the vector. The fusion gene (r-TE) generated a 26-kDa recombinant multidomain chimeric protein (Fig. 1) . Restriction enzyme digestion of recombinant plasmid revealed a 2.9 kb linearised vector and 655 bps insert as predicted. DNA sequence analysis of plasmid showed right open reading frame of insert. E. coli BL 21 DE3 (plysS) cells were transformed with the recombinant plasmid.
Expression and Purification of Recombinant Tsst-SEB Chimeric Protein
The presence of Tsst-SEB chimeric protein was determined by SDS-PAGE analyses of cytosol and inclusion bodies. The r-chimeric protein appeared to be aggregating to form inclusion bodies (Figs. 2 and 3) . The recombinant Tsst-SEB chimeric protein was purified from inclusion bodies under denaturing conditions. The protein after affinity chromatography was about 90 % pure with small amount of degraded and partially synthesized protein (Fig. 4) . The pooled fractions containing affinity purified Tsst-SEB chimeric protein were dialyzed against T10E5 buffer (10 mM Tris-HCl, 5 mM EDTA, pH 7.5).
Antibody Titer by Indirect Plate ELISA Hyperimmune from immunized mice was collected and antibody titer was tested against the recombinant r-TE as antigen by indirect ELISA on a microtiter plate. The absorbance was read at 492 nm in microplate reader. An . BXSBPPK-NEBH in the MCS represents the sites for the restriction endonucleases BamHI, XhoI, SacI, BglII, PstI, PvuII, KpnI, NcoI, EcoRI, BstBI and HindIII, respectively. Right panel Tsst (encoding the toxic shock syndrome toxin of S. aureus) and entB (encoding staphylococcal entero toxin B) were amplified by PCR with new restriction sites added at the ends of the primers and cloned into the BamHI and HindIII sites of pRSET A to generate the fusion gene construct r-TE absorbance at O.D 492 -0.3 was read at even 32,000 dilution of the hyperimmune sera.
Western Immunoblot Analysis
Western immunoblot analysis showed that mouse antir-chimeric protein serum strongly reacted with both Tsst-SEB of the different S. aureus strains (Fig. 5) . All of these strains were previously having been checked for the presence of enterotoxin by commercially available TECRA kit as well as by the PCR method for the detection of seb producing gene and by PCR for the presence of tsst producing gene (Table 3) . Hyperimmune anti sera of r-chimeric protein did not exhibit any reaction with other non-S. aureus group strains tested.
SEB Analysis
The r-TE protein sample tested positive for SEB moieties using a TECRA VIA Staphylococcus enterotoxin kit (TE-CRA International).
Development of an ELISA
An ELISA-based system was also developed that could be used in both clinical and food research laboratories. This would also have the advantage of quantifying the toxin. Maximum absorbance values were observed at antigen concentrations of 50 ng ml Fig. 4 Purification of E. coli expressed r-TE chimeric protein using Ni-NTA chromatography. LM molecular weight standards, L2 first elution 1, L3 second elution 2, L4 third elution, L5 fourth elution 200-fold dilutions of the primary antiserum, and therefore a 50-fold dilution was chosen for subsequent assays.
Evaluation of the Detection Systems
When evaluated on 216 food, clinical and environmental samples the hyper immune sera detected 12 SEB positive S. aureus strains which were unequivocally detected positive for presence of seb gene by the PCR and the toxin expression by TECRA kit (Table 3) . Three tsst PCR positive isolates recovered from the different samples and were reactive with hyperimmune sera.
Discussion
The strategy described in the present work was successful in generating a recombinant multidomain protein, r-TE, comprising truncated regions of Tsst and SEB, for utilization in toxin detection or disease diagnosis. The fusion gene in the current study, which was codon-optimized for E. coli expression, was first generated by ligation of PCRamplified products encoding Tsst-1 and SEB of S. aureus. The resultant 655 bps fusion gene was sequenced and the sequence was submitted to NCBI Genbank (Accession No. FJ527613). The pRSET A vector containing fusion gene yielded high expression which resulted in a recombinant two domain chimeric protein, r-TE, in the E. coli host (Fig. 2) . The TECRA kit was able to identify the SEB antigenic determinant in the r-TE protein. The immunodominant nature of the chimeric protein could be reflected by virtue of obtaining a high titered hyperimmune antiserum raised in mice. Furthermore, the antigenicity of the both toxin components was demonstrated in Western blot, wherein, antisera specifically reacted with S. aureus strains producing native SEB and Tsst toxin molecules providing two specific reaction bands at *28 kDa and at *22 kDa regions respectively (Fig. 5) .
From among the various kinds of food, clinical and environmental samples (216) processed for S. aureus isolation, 12 isolates were found to have seb gene by PCR were also detected positive by the hyperimmune sera raised against r-TE in ELISA as well as in Western blot. From among the three tsst positive isolates recovered from the different clinical samples, all were found to be reacting with hyperimmune sera. Though PCR has proven itself as a robust technique in pathogen detection for vast number of toxin associated genes but mere presence of certain genes 
like tsst, pvl and others might not always associated with clinical syndromes [16, 17] . On the other side, targeting the expressed toxin employing appropriate immunoassays rather than the gene could provide more useful clinical relevance of the disease. The presently described ELISA and/or Western blot analysis find its utility in situation related to bioterrorism/ biowarfare involving S. aureus toxins. Its application in the development of a comprehensive toxin detection immunoassay beyond Western blot and ELISA can also be explored. The strong seroreactivity of r-TE that we observed with hyperimmune mice sera and also the fact that it recognizes the immuno dominant epitopes found in the full-length native toxin proteins of the organism suggests that the recombinant chimeric molecule might have potential as a candidate vaccine molecule.
In conclusion, this paper has described the successful construction and expression of a multidomain r-TE fusion gene with specificity tailored towards Tsst-1 and SEB of S. aureus coupled to E. coli-based expression system. This recombinant protein was found useful in developing a simple, rapid and reliable immunoassay for the surveillance studies and or for disease diagnostics. The recombinant chimeric protein-based immuno detection approach eventually provides advantages over PCR formats as the main disadvantage of PCR happens to be their inability to correlate to the expression of toxin components by the organism. PCR technologies would have limited impact in detecting these biowarfare agents unless the toxin producing bacteria were used as the bioweapons rather than the purified toxins. Additionally, this non toxic r-TE molecule can be further explored for its possible application in generating neutralizing antibodies against the native toxins using appropriate animal model.
